Implementation of a Rapid Genotypic Assay to Promote Targeted Ciprofloxacin Therapy of <i>Neisseria gonorrhoeae</i> in a Large Health System
2016 · Clinical Infectious Diseases · 64 citations
https://doi.org/10.1093/cid/ciw864
P
Peera Hemarajata
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
68
Papers
4.4K
Citations
25
h-index
41
i10-index
Peera Hemarajata is an academic researcher from Association of Public Health Laboratories. The author has contributed to research in topics: Reproductive tract infections research & Bacterial Infections and Vaccines & Antibiotic Resistance in Bacteria. The author has an h-index of 25, co-authored 58 publications.
ORCID: 0000-0001-6182-9136Papers by this author
worksAn Mpox-Related Death in the United States
2023 · New England Journal of Medicine · 64 citations
https://doi.org/10.1056/nejmc2214921
Development of an amplicon-based sequencing approach in response to the global emergence of mpox
2023 · PLoS Biology · 51 citations
https://doi.org/10.1371/journal.pbio.3002151
Identification of Tecovirimat Resistance-Associated Mutations in Human Monkeypox Virus - Los Angeles County
2023 · Antimicrobial Agents and Chemotherapy · 46 citations
https://doi.org/10.1128/aac.00568-23
Community spread of a human monkeypox virus variant with a tecovirimat resistance-associated mutation
2023 · Antimicrobial Agents and Chemotherapy · 23 citations
https://doi.org/10.1128/aac.00972-23
Identification of Human Monkeypox Virus Genome Deletions That Impact Diagnostic Assays
2022 · Journal of Clinical Microbiology · 22 citations
https://doi.org/10.1128/jcm.01655-22
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat